Cornerstone Advisors (Washington)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$158K Sell
4,143
-34
-0.8% -$1.31K 0.02% 127
2020
Q2
$147K Buy
4,177
+845
+25% +$30.4K 0.02% 124
2020
Q1
$109K Sell
3,332
-230
-6% -$8.98K 0.02% 130
2019
Q4
$161K Buy
3,562
+121
+4% +$5.06K 0.02% 117
2019
Q3
$140K Buy
3,441
+405
+13% +$17.2K 0.02% 116
2019
Q2
$130K Buy
3,036
+207
+7% +$7.96K 0.01% 213
2019
Q1
$109K Buy
2,829
+409
+17% +$15.6K 0.01% 216
2018
Q4
$86K Buy
2,420
+184
+8% +$6.67K 0.02% 212
2018
Q3
$86K Buy
2,236
+128
+6% +$4.47K 0.06% 230
2018
Q2
$69K Buy
2,108
+155
+8% +$4.67K 0.05% 256
2018
Q1
$53K Hold
1,953
0.04% 272
2017
Q4
$48K Hold
1,953
0.03% 281
2017
Q3
$57K Buy
1,953
+802
+70% +$22.1K 0.04% 256
2017
Q2
$32K Sell
1,151
-802
-41% -$21.3K 0.02% 369
2017
Q1
$49K Hold
1,953
0.03% 276
2016
Q4
$42K Buy
1,953
+99
+5% +$2.16K 0.04% 289
2016
Q3
$44K Hold
1,854
0.04% 271
2016
Q2
$43K Hold
1,854
0.04% 168
2016
Q1
$35K Sell
1,854
-277
-13% -$4.87K 0.04% 200
2015
Q4
$39K Hold
2,131
0.04% 213
2015
Q3
$35K Buy
2,131
+751
+54% +$12.8K 0.03% 223
2015
Q2
$24K Hold
1,380
0.02% 228
2015
Q1
$24K Buy
1,380
+802
+139% +$12.7K 0.02% 261
2014
Q4
$8K Buy
578
+111
+24% +$1.42K 0.01% 329
2014
Q3
$6K Sell
467
-41
-8% -$516 ﹤0.01% 243
2014
Q2
$6K Hold
508
0.01% 272
2014
Q1
$7K Buy
+508
New +$6.67K 0.01% 233

Other funds holding BSX

Cornerstone Advisors (Washington)'s BSX Position: Q3 2020 in Review

Cornerstone Advisors (Washington) reduced its Boston Scientific (BSX) stake by 0.81% in Q3 2020, selling an estimated $1.31K and leaving 4,143 shares worth $158K. The position accounts for 0.02% of the portfolio, ranked #127.

Cornerstone Advisors (Washington) first reported a position in BSX in Q1 2014 and has held it in 27 quarters since. The position peaked at $161K in Q4 2019. 844 funds tracked by Wall St. Rank hold BSX as of Q3 2020.

  • Cornerstone Advisors (Washington) held 4,143 shares of Boston Scientific worth $158K as of Q3 2020.
  • Cornerstone Advisors (Washington) sold 34 Boston Scientific shares in Q3 2020, an estimated $1.31K.
  • Boston Scientific made up 0.02% of Cornerstone Advisors (Washington)'s portfolio in Q3 2020, its #127 holding.
  • Cornerstone Advisors (Washington) first reported a position in Boston Scientific in Q1 2014 and has held it in 27 quarters since.
  • Cornerstone Advisors (Washington)'s Boston Scientific position peaked at $161K in Q4 2019.
  • 844 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2020.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2020, filed 20 Oct 2020.